Dr Martens laces up ahead of potential London IPO
It is unclear what valuation the shoemaker and retailer would achieve
Archive
2401 stories · page 54 of 121
It is unclear what valuation the shoemaker and retailer would achieve
Diploma said cash flow had been exceptionally strong over the past twelve months
The firm set out to reduce food waste and increase its product offering to existing and new markets
The pharma company reached an agreement in July for the lawsuit over its anti-addiction treatment Suboxone
Sales this financial year so far have been ahead of expectations thanks to strong online growth
"We have seen an encouraging improvement in brand and manufacturer order confidence into the peak trading season of September-November," the thread-maker said
The pouches will be included under BAT’s VELO brand and will include a range of nicotine strengths and flavours
Promociones Fantásticas, a Colombian drinking straws producer, has already been using Symphony's technology for three years
Revenues slumped by 73% to £17mln in the six months to September 30, 2020
In the three months to September 30, revenue climbed 39% to £378mln led by the beauty and nutrition segments
Joe Bayer is currently leading the firm both as interim boss and executive chairman
The US state attorney said Shaun Thaxter had “failed to prevent efforts to build profits through misleading safety claims, which led to millions of dollars in ill-gotten gains for Indivior”
The London listed group has exclusive distribution rights for Eranova's product in certain markets
Social distancing is playing havoc with sales of its Durex condoms and cold remedies like Lemsip
Customer orders are now in excess of 80% of the full-year revenue forecasts
Uno, the largest baking company in Turkey, is not forced by legislation to use biodegradable packaging but it has chosen to use Symphony's d2w technology
For JD, the Canadian bank said they expected the athleisure retailer's UK market to “prove relatively resilient, due to higher conversion and strong digital sales”
Luc Jobin will replace Richard Burrows who is stepping down after the FTSE 100-listed firm's AGM next year
The bank’s analysts said while the £357mln acquisition was appealing, the share price was now 28% higher versus the EPS accretion of 13%
Analysts flagged up seven poised to see positive catalysts in coming months: OneSavingsBank, BAT, Intermediate Capital, Sainsbury's, WPP, National Grid and Hikma Pharmaceuticals